Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle

Globe Newswire

Outpace Bio to present new data on tumor-restricted IL-12 designed leveraging OutSmart technology to enhance solid tumor T cell therapies at SITC 2023

Cancer Cell

Building smart CAR T cell therapies: The path to overcome current challenges

GeekWire

Seattle startups move into growing science cluster in South Lake Union

American Society for Gene & Cell Therapy (ASGCT)

OutSmart™ IL-2/15 Safely Stimulates CAR T Proliferation and Persistence in the Tumor while Limiting Regulatory T Cell Activation

GeekWire

How AI is changing the way scientists engineer drugs, biosensors, enzymes and more

Endpoints News

Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle

Globe Newswire

Outpace Bio expands Seattle presence with cell therapy research hub & collaborations with leading experts in protein design & cancer immunotherapy

Globe Newswire

Outpace Bio to present new data on OutSmart™ IL-2/15, a CAR T cell-produced designed cytokine with tumor-localized immune cell activity, at the 2023 annual meeting of the American Society of Gene & Cell Therapy (ASGCT)